Literature DB >> 2472186

Gallbladder carcinoma: role of radiation therapy.

S Houry1, M Schlienger, M Huguier, F Lacaine, F Penne, A Laugier.   

Abstract

Gallbladder carcinoma continues to be a discouraging disease. Prognosis after resection still remains poor. Radiation therapy has been used in an attempt to improve the prognosis but only a few series of less than ten cases have been reported. Since 1977 we have treated 20 patients with gallbladder carcinoma with postoperative radiotherapy (mean total dose 4200 radiation absorbed dose). In four patients all the tumour was resected with the intent of cure. In 12 patients, the lesion was partially resected and in four patients no resection was performed. Seven patients in whom the tumour was partially resected or not resected also had chemotherapy. Our evaluation was retrospective and we compared our results with historical control groups comparable with respect to surgical procedures and pathological staging. In patients operated on for cure, one patient is alive at 84 months, the others died at 7, 8 and 33 months. In patients in whom the tumour was partially resected the mean survival time was 8.1 months and two patients are still alive 7.0 months after treatment. According to the Nevin classification the mean survival time in stage IV and V patients was respectively 9.2 and 7.2 months. There was no difference in survival between patients treated or not treated with chemotherapy. This experience is the largest published and suggests that radiotherapy may increase survival after no resection or palliative resection of gallbladder carcinoma.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2472186     DOI: 10.1002/bjs.1800760508

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  9 in total

1.  Postoperative chemoradiotherapy for gallbladder cancer.

Authors:  K Kim; E K Chie; J-Y Jang; S W Kim; S-W Han; D-Y Oh; S-A Im; T-Y Kim; Y-J Bang; S W Ha
Journal:  Strahlenther Onkol       Date:  2012-03-10       Impact factor: 3.621

2.  Nomogram for predicting the benefit of adjuvant chemoradiotherapy for resected gallbladder cancer.

Authors:  Samuel J Wang; Andrew Lemieux; Jayashree Kalpathy-Cramer; Celine B Ord; Gary V Walker; C David Fuller; Jong-Sung Kim; Charles R Thomas
Journal:  J Clin Oncol       Date:  2011-11-07       Impact factor: 44.544

3.  Adenocarcinoma of the gallbladder.

Authors:  P Burgess; P D Murphy; M B Clague
Journal:  J R Soc Med       Date:  1991-08       Impact factor: 5.344

4.  Risk factors influencing recurrence, patterns of recurrence, and the efficacy of adjuvant therapy after radical resection for gallbladder carcinoma.

Authors:  Woo Seok Kim; Dong Wook Choi; Dong Do You; Chuan Yu Ho; Jin Seok Heo; Seong Ho Choi
Journal:  J Gastrointest Surg       Date:  2010-01-22       Impact factor: 3.452

Review 5.  Current management of gallbladder carcinoma.

Authors:  Andrew X Zhu; Theodore S Hong; Aram F Hezel; David A Kooby
Journal:  Oncologist       Date:  2010-02-10

6.  Adjuvant radiotherapy for gallbladder cancer: a dosimetric comparison of conformal radiotherapy and intensity-modulated radiotherapy.

Authors:  Xiao-Nan Sun; Qi Wang; Ben-Xing Gu; Yan-Hong Zhu; Jian-Bin Hu; Guo-Zhi Shi; Shu Zheng
Journal:  World J Gastroenterol       Date:  2011-01-21       Impact factor: 5.742

7.  Impact of adjuvant external beam radiotherapy on survival in surgically resected gallbladder adenocarcinoma: a propensity score-matched Surveillance, Epidemiology, and End Results analysis.

Authors:  Omar Hyder; Rebecca M Dodson; Teviah Sachs; Matthew Weiss; Skye C Mayo; Michael A Choti; Christopher L Wolfgang; Joseph M Herman; Timothy M Pawlik
Journal:  Surgery       Date:  2013-07-19       Impact factor: 3.982

8.  Intraoperative radiation therapy for carcinoma of the gallbladder.

Authors:  P M Busse; B Cady; A Bothe; R Jenkins; W V McDermott; G Steele; M D Stone
Journal:  World J Surg       Date:  1991 May-Jun       Impact factor: 3.352

9.  Resection combined with intraoperative radiation therapy (IORT) for stage IV (TNM) gallbladder carcinoma.

Authors:  T Todoroki; Y Iwasaki; K Orii; M Otsuka; K Ohara; T Kawamoto; K Nakamura
Journal:  World J Surg       Date:  1991 May-Jun       Impact factor: 3.352

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.